BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1060 related articles for article (PubMed ID: 30064461)

  • 21. Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression.
    Chen K; Wang Q; Liu X; Wang F; Yang Y; Tian X
    Int J Biol Sci; 2022; 18(3):1220-1237. PubMed ID: 35173549
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins.
    Fang JH; Zhang ZJ; Shang LR; Luo YW; Lin YF; Yuan Y; Zhuang SM
    Hepatology; 2018 Oct; 68(4):1459-1475. PubMed ID: 29637568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA hsa_circ_0010729 regulates vascular endothelial cell proliferation and apoptosis by targeting the miR-186/HIF-1α axis.
    Dang RY; Liu FL; Li Y
    Biochem Biophys Res Commun; 2017 Aug; 490(2):104-110. PubMed ID: 28571741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA circ_0047744 suppresses the metastasis of pancreatic ductal adenocarcinoma by regulating the miR-21/SOCS5 axis.
    Xie H; Zhao Q; Yu L; Lu J; Peng K; Xie N; Ni J; Li B
    Biochem Biophys Res Commun; 2022 May; 605():154-161. PubMed ID: 35334414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
    Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel potential tumor biomarkers: Circular RNAs and exosomal circular RNAs in gastrointestinal malignancies.
    Wang Y; Li Z; Xu S; Guo J
    J Clin Lab Anal; 2020 Jul; 34(7):e23359. PubMed ID: 32419229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
    Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
    BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.
    Yang D; Zhang Y; Cheng Y; Hong L; Wang C; Wei Z; Cai Q; Yan R
    Dig Dis Sci; 2017 Apr; 62(4):958-967. PubMed ID: 28181096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal circular RNA hsa_circ_0006220, and hsa_circ_0001666 as biomarkers in the diagnosis of pancreatic cancer.
    Hong L; Xu L; Jin L; Xu K; Tang W; Zhu Y; Qiu X; Wang J
    J Clin Lab Anal; 2022 Jun; 36(6):e24447. PubMed ID: 35446993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
    Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers.
    Xu Y; Leng K; Yao Y; Kang P; Liao G; Han Y; Shi G; Ji D; Huang P; Zheng W; Li Z; Li J; Huang L; Yu L; Zhou Y; Jiang X; Wang H; Li C; Su Z; Tai S; Zhong X; Wang Z; Cui Y
    Hepatology; 2021 Apr; 73(4):1419-1435. PubMed ID: 32750152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of long noncoding RNA SNHG14 suppresses cell proliferation and invasion by regulating EZH2 in pancreatic ductal adenocarcinoma (PDAC).
    Xie F; Huang Q; Wang C; Chen S; Liu C; Lin X; Lv X; Wang C
    Cancer Biomark; 2020; 27(3):357-364. PubMed ID: 31929143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression.
    Ding Y; Cao F; Sun H; Wang Y; Liu S; Wu Y; Cui Q; Mei W; Li F
    Cancer Lett; 2019 Feb; 442():351-361. PubMed ID: 30419348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1.
    Hsu YL; Hung JY; Chang WA; Lin YS; Pan YC; Tsai PH; Wu CY; Kuo PL
    Oncogene; 2017 Aug; 36(34):4929-4942. PubMed ID: 28436951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-derived exosomes enhance invasion and metastasis of salivary adenoid cystic carcinoma cells.
    Hou J; Wang F; Liu X; Song M; Yin X
    J Oral Pathol Med; 2018 Feb; 47(2):144-151. PubMed ID: 29057556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes.
    Massoumi RL; Hines OJ; Eibl G; King JC
    Pancreas; 2019 Jan; 48(1):1-8. PubMed ID: 30531240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion.
    Chen J; Zhao CC; Chen FR; Feng GW; Luo F; Jiang T
    Biomed Res Int; 2021; 2021():8249293. PubMed ID: 34805404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis.
    Yang H; Zhang H; Yang Y; Wang X; Deng T; Liu R; Ning T; Bai M; Li H; Zhu K; Li J; Fan Q; Ying G; Ba Y
    Theranostics; 2020; 10(18):8211-8226. PubMed ID: 32724467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.